These results suggest that VEGF-A expression is successfully knocked down in tumor cells by an intratumoral administration of the siVEGF/nanogel complex, suppressing tumor growth and restoring immunosuppression induced by the tumor [34,35]. Here, VEGFA is linked to neoplasm.